AZN in discovery deal with Chinese CRO

AstraZeneca plc (LSE:AZN; NYSE:AZN) announced a multi-year drug discovery partnership with CRO Pharmaron Inc. (Beijing, China). Pharmaron will provide services through its Beijing service center, incl...